Skip to content

Application and economic benefit study of clinical pathway for patients with diffuse adenomyosis after PUSH surgery based on rapid recovery

Application and economic benefit study of clinical pathway for patients with diffuse adenomyosis after PUSH surgery based on rapid recovery

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111669
Enrollment
Unknown
Registered
2025-11-04
Start date
2025-07-15
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diffuse adenomyosis

Interventions

ERAS group:Enhanced Recovery After Surgery
Control group:routine care

Sponsors

Peking University Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1.According to the definition provided in the 9th edition of Obstetrics and Gynecology textbooks, the patient is diagnosed with adenomyosis through ultrasound and CA125 testing, and the uterus is enlarged; 2. Age between 18 and 50 years old; 3. There were no obvious surgical or anesthetic contraindications before the operation, and all were elective surgeries; 4. Patients with complete clinical data and confirmed uterine adenomyosis by postoperative pathology; 5. The patient and their family members agree and sign the ERAS informed consent form; 6. The same surgical team evaluates and performs the surgery.

Exclusion criteria

Exclusion criteria: 1. Previous chronic diseases such as diabetes, hypertension, heart disease, and cerebrovascular disease; 2. Patients with a history of comorbid malignancy; 3. Patients with venous thrombosis and coagulation dysfunction before surgery; 4. Patients with severe mental illness and severe cognitive impairment; 5. Severe anemia or above (<=60g/L); 6. Changes in surgical approach during the operation, or the need for reoperation due to unplanned reasons.

Design outcomes

Primary

MeasureTime frame
Anal exhaust time;

Secondary

MeasureTime frame
Patient discharge satisfaction;Time of first bowel movement;Postoperative pain VAS scores at 6h, 12h, and 24h;Incidence of postoperative complications;Duration of indwelling urinary catheter;Hospitalization days?Hospitalization expenses;Anxiety and depression;Time of first getting out of bed and moving around;

Countries

China

Contacts

Public ContactYu Yingjuan

Peking University Shenzhen Hospital

yyj0399@126.com+86 139 2375 5636

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026